Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
XOMA Corporation
XOMA | US
28.46
USD-0.94
-3.20%
XOMA | US
About XOMA Corporation
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
21/10/2024
Close
28.46
Open
29.52
High
29.52
Low
28.40
XOMA Corporation operates as a biotech royalty aggregator in Europe the United States and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with various assets. The company was incorporated in 1981 and is headquartered in Emeryville California.
View LessXOMA | US
Risk
35.1
Sharpe
1.06
Luna's Score
48/100
Recommendation
Hold
Luna says (XOMA | US)
What's Working
Strong Revenue Growth (> 10%)
What's not Working
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Weak Operating Margin (< 10%)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
34.1%1 month
35.1%3 months
51.7%6 months
58.2%Returns
Fundamental Ratios
PE
-
Fwd. PE
192.31
Price to book
3.38
Debt to equity
1.22
Debt to assets
0.50
Ent. to EBITDA
-6.91
Ent. to rev.
32.11
PEG
-0.42
Other Fundamentals
EBITDA
-19.10M
MarketCap
333.11M
MarketCap(USD)
333.11M
Div. yield
-
Op. margin
-9.73
Erngs. growth
37.00
Rev. growth
568.60
Ret. on equity
-17.35
Short ratio
10.03
Short perc.
3.05
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
3.76
Range1M
5.17
Range3M
7.80
Volumes: Market Activity
Rel. volume
0.45
Price X volume
273.73K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -6.91 | - | Cheaper |
| Ent. to Revenue | 32.11 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 3.38 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 51.69 | - | Lower Risk |
| Debt to Equity | 1.22 | -1.23 | Expensive |
| Debt to Assets | 0.50 | 0.25 | Expensive |
| Market Cap | 333.11M | - | Emerging |
